United in Earnest: First Pilot Sites for Increased Surgical Capacity for Rheumatic Heart Disease Announced by Cardiac

Zachary Obinna Enumah1, Ralph Morton Bolman1, Peter Zilla1

  • 1Cardiac Surgery Intersociety Alliance.

Insights

The Cardiac Surgery Intersociety Alliance (CSIA) was formed to improve cardiac surgery access for rheumatic heart disease (RHD) patients. Two pilot sites in Mozambique and Rwanda were selected to advance this critical global health initiative.

Area of Science:

  • Global Health
  • Cardiovascular Surgery
  • Public Health Policy

Background:

  • Rheumatic heart disease (RHD) disproportionately affects over 33 million individuals in low- and middle-income countries.
  • The Cape Town Declaration (2018) marked a global commitment to enhance RHD patient care.
  • This declaration laid the groundwork for the formation of the Cardiac Surgery Intersociety Alliance (CSIA).

Purpose of the Study:

  • To detail the history, formation, and activities of the CSIA.
  • To outline the alliance's ongoing efforts and future strategic directions.
  • To announce the selected pilot sites for improving cardiac surgery access.

Main Methods:

  • The CSIA is an international alliance of cardiothoracic surgical societies and the World Heart Federation.
  • Activities include conference meetings, recruitment efforts, and establishing selection criteria for support.
  • Criteria focused on local capacity, leadership, support, identified care gaps, and research interest.

Main Results:

  • Eleven applications were received for CSIA support.
  • Three finalist sites underwent site visits.
  • Hospital Central Maputo (Mozambique) and King Faisal Hospital Kigali (Rwanda) were selected as pilot sites.

Conclusions:

  • Significant progress has been achieved since the Cape Town Declaration and CSIA formation.
  • Continued collaboration among cardiac surgery, cardiology, industry, and government is essential.
  • Sustained efforts are crucial to improve access to life-saving cardiac surgery for RHD patients globally.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
100
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
157
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
197
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
107
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
90
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
138